Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6181814 | Fertility and Sterility | 2015 | 15 Pages |
Abstract
Antimüllerian hormone has weak association with implantation and clinical pregnancy rates in assisted reproductive technology but may still have some clinical utility in counseling women undergoing fertility treatment regarding pregnancy rates, particularly those with DOR.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Reshef M.D., Ph.D., Oded Ph.D., Benjamin J. B.S.M.E., David B. M.D.,